These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24575810)

  • 1. Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients.
    Huang L; Liao LM; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M
    BMC Cancer; 2014 Feb; 14():140. PubMed ID: 24575810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
    Minig L; Colombo N; Zanagnolo V; Landoni F; Bocciolone L; Cárdenas-Rebollo JM; Iodice S; Maggioni A
    Int J Gynecol Cancer; 2013 Nov; 23(9):1647-54. PubMed ID: 24100590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin A (CgA) as poor prognostic factor in patients with small cell carcinoma of the cervix: results of a retrospective study of 293 patients.
    Liao LM; Zhang X; Ren YF; Sun XY; Di N; Zhou N; Pan RK; Ma SH; Zhou LX
    PLoS One; 2012; 7(4):e33674. PubMed ID: 22529895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
    Kawamura M; Koide Y; Murai T; Ishihara S; Takase Y; Murao T; Okazaki D; Yamaguchi T; Uchiyama K; Itoh Y; Kodaira T; Shibamoto Y; Mizuno M; Kikkawa F; Naganawa S
    BMC Cancer; 2021 Sep; 21(1):1046. PubMed ID: 34556082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
    Zivanovic O; Leitao MM; Park KJ; Zhao H; Diaz JP; Konner J; Alektiar K; Chi DS; Abu-Rustum NR; Aghajanian C
    Gynecol Oncol; 2009 Mar; 112(3):590-3. PubMed ID: 19110302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
    Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
    Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative adjuvant radiation improves local control in surgically treated FIGO stage I-II small cell carcinoma of the cervix.
    Shen T; Jiang YH; Zou YY; Qiu FF; Qiu XS; You KY
    Radiat Oncol; 2019 Nov; 14(1):203. PubMed ID: 31722727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.
    Lee YY; Park W; Huh SJ; Yoon A; Park JY; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
    Anticancer Res; 2013 Oct; 33(10):4675-81. PubMed ID: 24123048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic risk factors for small cell carcinoma of the cervix and impact of platinum-based neoadjuvant chemotherapy.
    Li X; Yang R; Jia Y; Zhou J; Ma D; Li S
    Int J Gynaecol Obstet; 2015 Jul; 130(1):31-5. PubMed ID: 25890393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
    Zhao D; Sun S; Yang Z; Wang P; Qiu H
    Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
    Yin ZM; Yu AJ; Wu MJ; Fang J; Liu LF; Zhu JQ; Yu H
    Eur J Gynaecol Oncol; 2015; 36(3):326-9. PubMed ID: 26189262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy.
    Hoskins PJ; Swenerton KD; Pike JA; Lim P; Aquino-Parsons C; Wong F; Lee N
    J Clin Oncol; 2003 Sep; 21(18):3495-501. PubMed ID: 12972526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.
    Okazawa-Sakai M; Yokoyama T; Fujimoto E; Okame S; Shiroyama Y; Yokoyama T; Takehara K
    Int J Clin Oncol; 2018 Aug; 23(4):715-725. PubMed ID: 29446043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
    Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
    J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.
    Lissoni AA; Colombo N; Pellegrino A; Parma G; Zola P; Katsaros D; Chiari S; Buda A; Landoni F; Peiretti M; Dell'anna T; Fruscio R; Signorelli M; Grassi R; Floriani I; Fossati R; Torri V; Rulli E
    Ann Oncol; 2009 Apr; 20(4):660-5. PubMed ID: 19181826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
    Adachi S; Ogasawara T; Tsubamoto H; Oku H; Hori Y; Tsuji Y; Takemura T; Koyama K
    Int J Clin Pharmacol Res; 2001; 21(3-4):105-10. PubMed ID: 12067139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small cell carcinoma of the uterine cervix: clinical outcome of concurrent chemoradiotherapy with a multidrug regimen.
    Tokunaga H; Nagase S; Yoshinaga K; Tanaka S; Nagai T; Kurosawa H; Kaiho-Sakuma M; Toyoshima M; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
    Tohoku J Exp Med; 2013 Jan; 229(1):75-81. PubMed ID: 23269283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.